论文部分内容阅读
成人急性白血病是难以治疗的,不管单独的或联合化疗,其完全缓解率并非恒定地高于50%以上。但有少数病例其完全缓解率几达90%,这就提示通过修定患者的治疗方案,有改善治疗结果的可能性。但直到目前还没有试验能可靠地预测化疗药物对恶性病患者的疗效,甚至组织类型相同的患者对化疗敏感性也不相同。本文通过白血病细胞体外培养法(即白血病细胞对化疗药物的敏感性),探讨
Adult acute leukemia is difficult to treat, and the complete remission rate is not consistently higher than 50%, either alone or in combination with chemotherapy. However, in a few cases, the complete remission rate is as high as 90%. This suggests that the possibility of improving the outcome of treatment can be improved by modifying the patient’s treatment plan. However, no trials have been able to reliably predict the efficacy of chemotherapeutic drugs in patients with malignant diseases. Even patients with the same tissue type have different sensitivity to chemotherapy. This article discusses leukemia cell culture in vitro (ie, the sensitivity of leukemia cells to chemotherapy drugs).